Johnson Midwest Financial, LLC Biogen Inc. Transaction History
Johnson Midwest Financial, LLC
- $44.1 Million
- Q3 2023
A detailed history of Johnson Midwest Financial, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Johnson Midwest Financial, LLC holds 36 shares of BIIB stock, worth $5,231. This represents 0.02% of its overall portfolio holdings.
Number of Shares
36
Previous 36
-0.0%
Holding current value
$5,231
Previous $10,000
10.0%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.51 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.3 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.11 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.09 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$697 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...